Evidence map›Paper›PMID 22366714›Full record

ArticleFree radical biology & medicine2012

Triglyceride, nonesterified fatty acids, and prediabetic neuropathy: role for oxidative-nitrosative stress.

Sergey Lupachyk, Pierre Watcho, Nailia Hasanova, Ulrich Julius, Irina G Obrosova

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. The foot in diabetes - a reminder of an ever-present risk.Clinical medicine (London, England) · 2023
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sergey LupachykPennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA 70808, USA.
Pierre Watcho
Nailia Hasanova
Ulrich Julius
Irina G Obrosova
Louisiana State University System · USPennington Biomedical Research Center · USTU Dresden · DE

Funding

Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2005 to 2026
$26.5M
Na+/H+-exchanger-1 and Diabetic NeuropathyR01DK077141 · NIDDK · UNIVERSITY OF IOWA · PI YOREK, MARK A. · 2008 to 2012
$1.6M
12/15-Lipoxygenase and Diabetic NeuropathyR01DK074517 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI OBROSOVA, IRINA G · 2007 to 2011
$1.5M
Peroxynitrite, protein nitration and advanced diabetic neuropathyR01DK081147 · NIDDK · UNIVERSITY OF IOWA · PI YOREK, MARK A. · 2010 to 2014
$1.4M
NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK074517NIDDK NIH HHS R01DK074517NIDDK NIH HHS R01 DK077141NIDDK NIH HHS R01DK077141NIDDK NIH HHS R01 DK081147NIDDK NIH HHS R01DK081147
6 · The paper itself

Abstract

Peripheral neuropathy develops in human subjects with prediabetes and metabolic syndrome before overt hyperglycemia. The contributions of impaired glucose tolerance and insulin signaling, hypertriglyceridemia and/or increased nonesterified fatty acids (NEFA), and hypercholesterolemia to this condition remain unknown. Niacin and its derivatives alleviate dyslipidemia with a minor effect on glucose homeostasis. This study evaluated the roles of impaired glucose tolerance versus dyslipidemia in prediabetic neuropathy using Zucker fatty (fa/fa) rats and the niacin derivative acipimox, as well as the interplay of hypertriglyceridemia, increased NEFA, and oxidative-nitrosative stress. Sixteen-week-old Zucker fatty rats with impaired glucose tolerance, obesity, hyperinsulinemia, hypertriglyceridemia, hypercholesterolemia, and increased NEFA displayed sensory nerve conduction velocity deficit, thermal and mechanical hypoalgesia, and tactile allodynia. Acipimox (100 mg kg(-1) day(-1), 4 weeks) reduced serum insulin, NEFA, and triglyceride concentrations without affecting glucose tolerance and hypercholesterolemia. It alleviated sensory nerve conduction velocity deficit and changes in behavioral measures of sensory function and corrected oxidative-nitrosative stress, but not impaired insulin signaling, in peripheral nerve. Elevated NEFA increased total and mitochondrial superoxide production and NAD(P)H oxidase activity in cultured human Schwann cells. In conclusion, hypertriglyceridemia and/or increased NEFA concentrations cause prediabetic neuropathy through oxidative-nitrosative stress. Lipid-lowering agents and antioxidants may find a use in the management of this condition.

Indexed as

NitrosationOxidative StressAnimalsCells, CulturedFatty Acids, NonesterifiedMalePeripheral Nervous System DiseasesPrediabetic StateRatsRats, ZuckerTriglyceridesFatty Acids, NonesterifiedTriglycerides

Identifiers

PMID22366714
PMCPMC3312982
OpenAlexW2001321585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.